MassMutual Private Wealth & Trust
SLS icon

MassMutual Private Wealth & Trust’s SELLAS Life Sciences SLS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$283 Sell
23
-1
-4% -$13 ﹤0.01% 2296
2026
Q2 		$354 Buy
+24
New +$166 ﹤0.01% 2317

Other funds holding SLS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

MassMutual Private Wealth & Trust's SLS Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its SELLAS Life Sciences (SLS) stake by 4.2% in Q3 2026, selling an estimated $13 and leaving 23 shares worth $283. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

MassMutual Private Wealth & Trust first reported a position in SLS in Q2 2026 and has held it in 2 quarters since. The position peaked at $354 in Q2 2026. 86 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • MassMutual Private Wealth & Trust held 23 shares of SELLAS Life Sciences worth $283 as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 1 SELLAS Life Sciences share in Q3 2026, an estimated $13.
  • SELLAS Life Sciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #2296 holding.
  • MassMutual Private Wealth & Trust first reported a position in SELLAS Life Sciences in Q2 2026 and has held it in 2 quarters since.
  • MassMutual Private Wealth & Trust's SELLAS Life Sciences position peaked at $354 in Q2 2026.
  • 86 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.